Nenad Grmusa

Nenad Grmusa serves as Chief Executive Officer at DEM Biopharma, Inc.. DEM Biopharma, Inc. operates in the research sector with approximately 25.0 employees. The company is headquartered in Cambridge, Massachusetts. DEM Biopharma, Inc. generates annual revenue of 120000.0. To date, DEM Biopharma, Inc. has raised 70000000.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,467 c suite-level executives.

Outlook Greenhouse.io BambooHR Google Font API Google Tag Manager WordPress.org Mobile Friendly

biotechnology research innate immune system solid organ malignancies biopharmaceutical company immune evasion therapeutic targets genome-wide crispr immuno-oncology first-in-class targets hemathology clinical trial drug discovery bioprocess development crispr technology immune checkpoints targeted therapies cancer immunotherapy preclinical studies biologics biomanufacturing drug product stability chemistry manufacturing controls cell therapy molecular biology oncology research personalized medicine in vitro studies pharmaceutical pipelines clinical development novel therapeutics genetics immune response modulation translational medicine pharmaceutical consultancy biotechnology investments therapeutic modalities emerging science early-stage biotech diagnostic assays drug candidate fda approval scientific advisory pharmacology research biotech innovation human immune response cancer research dendritic cell biology cancer treatment novel drug formation pharmaceutical development hemato-oncology

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Nenad Grmusa in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at DEM Biopharma, Inc..

Nenad Grmusa's Position in the MessageCEO Database

• •Nenad Grmusa is 1 of 1 verified executive contact we track at DEM Biopharma, Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •44 verified contacts work at research companies in the 25.0 employee range (same size as DEM Biopharma, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated August 2026.

How do I reach Nenad Grmusa directly?

Nenad Grmusa's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at DEM Biopharma, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Nenad Grmusa work for?

Nenad Grmusa is Chief Executive Officer at DEM Biopharma, Inc., a company in the research sector with 25.0 employees. The company is based in Cambridge, Massachusetts.

Can I pitch or sell to Nenad Grmusa?

As Chief Executive Officer at DEM Biopharma, Inc., Nenad Grmusa is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Nenad Grmusa directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Nenad Grmusa in?

Nenad Grmusa works in the research industry as Chief Executive Officer at DEM Biopharma, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Nenad Grmusa's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Nenad Grmusa's profile is kept up-to-date with the latest available information.

Last updated: August 29, 2026